DOMH
Price
$5.39
Change
-$0.22 (-3.92%)
Updated
Jul 18 closing price
Capitalization
78.93M
29 days until earnings call
SLDB
Price
$6.39
Change
+$0.60 (+10.36%)
Updated
Jul 18 closing price
Capitalization
495.32M
Interact to see
Advertisement

DOMH vs SLDB

Header iconDOMH vs SLDB Comparison
Open Charts DOMH vs SLDBBanner chart's image
Dominari Holdings
Price$5.39
Change-$0.22 (-3.92%)
Volume$388.79K
Capitalization78.93M
Solid Biosciences
Price$6.39
Change+$0.60 (+10.36%)
Volume$3.44M
Capitalization495.32M
DOMH vs SLDB Comparison Chart in %
Loading...
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
DOMH vs. SLDB commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DOMH is a Hold and SLDB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (DOMH: $5.39 vs. SLDB: $6.39)
Brand notoriety: DOMH and SLDB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DOMH: 134% vs. SLDB: 201%
Market capitalization -- DOMH: $78.93M vs. SLDB: $495.32M
DOMH [@Biotechnology] is valued at $78.93M. SLDB’s [@Biotechnology] market capitalization is $495.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DOMH’s FA Score shows that 0 FA rating(s) are green whileSLDB’s FA Score has 2 green FA rating(s).

  • DOMH’s FA Score: 0 green, 5 red.
  • SLDB’s FA Score: 2 green, 3 red.
According to our system of comparison, SLDB is a better buy in the long-term than DOMH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DOMH’s TA Score shows that 5 TA indicator(s) are bullish while SLDB’s TA Score has 4 bullish TA indicator(s).

  • DOMH’s TA Score: 5 bullish, 5 bearish.
  • SLDB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both DOMH and SLDB are a good buy in the short-term.

Price Growth

DOMH (@Biotechnology) experienced а +8.02% price change this week, while SLDB (@Biotechnology) price change was +21.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

DOMH is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLDB($495M) has a higher market cap than DOMH($78.9M). DOMH YTD gains are higher at: 469.777 vs. SLDB (59.750). DOMH has higher annual earnings (EBITDA): -40.28M vs. SLDB (-136.83M). SLDB has more cash in the bank: 307M vs. DOMH (18.9M). DOMH has less debt than SLDB: DOMH (2.92M) vs SLDB (23.6M). DOMH has higher revenues than SLDB: DOMH (24.9M) vs SLDB (0).
DOMHSLDBDOMH / SLDB
Capitalization78.9M495M16%
EBITDA-40.28M-136.83M29%
Gain YTD469.77759.750786%
P/E RatioN/AN/A-
Revenue24.9M0-
Total Cash18.9M307M6%
Total Debt2.92M23.6M12%
FUNDAMENTALS RATINGS
DOMH vs SLDB: Fundamental Ratings
DOMH
SLDB
OUTLOOK RATING
1..100
9525
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9897
PRICE GROWTH RATING
1..100
3535
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SLDB's Valuation (27) in the Biotechnology industry is somewhat better than the same rating for DOMH (72) in the null industry. This means that SLDB’s stock grew somewhat faster than DOMH’s over the last 12 months.

SLDB's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as DOMH (100) in the null industry. This means that SLDB’s stock grew similarly to DOMH’s over the last 12 months.

SLDB's SMR Rating (97) in the Biotechnology industry is in the same range as DOMH (98) in the null industry. This means that SLDB’s stock grew similarly to DOMH’s over the last 12 months.

SLDB's Price Growth Rating (35) in the Biotechnology industry is in the same range as DOMH (35) in the null industry. This means that SLDB’s stock grew similarly to DOMH’s over the last 12 months.

SLDB's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for DOMH (100) in the null industry. This means that SLDB’s stock grew significantly faster than DOMH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DOMHSLDB
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
81%
MACD
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 10 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
DOMH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRDE1.650.10
+6.45%
NU RIDE INC
PCLB33.30N/A
N/A
Pinnacle Bancshares, Inc.
TROLB29.91N/A
N/A
Tootsie Roll Industries Inc
CHEAF0.36N/A
N/A
China Eastern Airlines Corp. Ltd.
RECAF0.32N/A
-1.51%
Reconnaissance Energy Africa Ltd.

DOMH and

Correlation & Price change

A.I.dvisor indicates that over the last year, DOMH has been loosely correlated with EDSA. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if DOMH jumps, then EDSA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DOMH
1D Price
Change %
DOMH100%
-4.01%
EDSA - DOMH
36%
Loosely correlated
+1.27%
FHTX - DOMH
32%
Poorly correlated
+0.49%
ENTA - DOMH
29%
Poorly correlated
+4.29%
MBRX - DOMH
28%
Poorly correlated
-4.02%
SLDB - DOMH
28%
Poorly correlated
+10.36%
More

SLDB and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with BEAM. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
+10.36%
BEAM - SLDB
49%
Loosely correlated
+1.47%
EDIT - SLDB
48%
Loosely correlated
+1.10%
CRSP - SLDB
47%
Loosely correlated
+18.22%
ALLO - SLDB
47%
Loosely correlated
+0.81%
CRBU - SLDB
46%
Loosely correlated
+12.02%
More